Patents by Inventor Steve Bernstein

Steve Bernstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11821893
    Abstract: A process of simply, cheaply, and reproducibly creating complex tissue models using screen printing and the tissue model prepared using the screen printing process. These models are amenable to high throughput screening. They will allow the study of components of disease progression and can be used for screening therapies.
    Type: Grant
    Filed: February 23, 2021
    Date of Patent: November 21, 2023
    Assignees: University of Maryland, Baltimore County, University of Maryland, Baltimore
    Inventors: Erin Lavik, Steve Bernstein, Adam Day, Bryan Ibarra
  • Publication number: 20210172933
    Abstract: A process of simply, cheaply, and reproducibly creating complex tissue models using screen printing and the tissue model prepared using the screen printing process. These models areamenable to high throughput screening. They will allow the study of components of disease progression and can be used for screening therapies.
    Type: Application
    Filed: February 23, 2021
    Publication date: June 10, 2021
    Inventors: Erin LAVIK, Steve BERNSTEIN, Adam DAY, Bryan IBARRA
  • Patent number: 11002727
    Abstract: A process of simply, cheaply, and reproducibly creating complex tissue models using screen printing and the tissue model prepared using the screen printing process. These models are amenable to high throughput screening. They will allow the study of components of disease progression and can be used for screening therapies.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: May 11, 2021
    Assignees: UNIVERSITY OF MARYLAND, BALTIMORE COUNTY, UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Erin Lavik, Steve Bernstein, Adam Day, Bryan Ibarra
  • Publication number: 20190187128
    Abstract: A process of simply, cheaply, and reproducibly creating complex tissue models using screen printing and the tissue model prepared using the screen printing process. These models are amenable to high throughput screening. They will allow the study of components of disease progression and can be used for screening therapies.
    Type: Application
    Filed: July 27, 2018
    Publication date: June 20, 2019
    Inventors: Erin LAVIK, Steve BERNSTEIN, Adam DAY, Bryan IBARRA
  • Publication number: 20110188803
    Abstract: A multiple conductor optical cable may be coupled to an undersea device, such as a cable joint, branching unit, or repeater, with one or more isolated bypass conductive paths being provided across the undersea device. At least one conductor may be terminated within a housing of the undersea device and at least one conductor may be coupled to a conductive bridge member that provides the isolated bypass conductive path across the device. Multiple conductor optical cables may be coupled to undersea devices in optical networks using independent power paths, for example, to deliver power to different powered components at different voltage potentials.
    Type: Application
    Filed: February 1, 2010
    Publication date: August 4, 2011
    Applicant: TYCO ELECTRONICS SUBSEA COMMUNICATIONS LLC
    Inventors: Maurice E. Kordahi, Robert K. Stix, Tony S. Fong, Jeremiah A. Mendez, Steve Bernstein
  • Patent number: 7799520
    Abstract: A cell isolating device and method is provided to concentrate or isolate cells with specific characteristics from a mixture of different cell types. One embodiment may comprise two subtypes of antibodies that are directly conjugated to biotin (Abb) and conjugated to a fluorescent molecule (Abf). The conjugated antibodies (Abb+Abf) bind to the target cells in a mixed cell suspension. The cell suspension is then passed over an immobilized avidin or streptavidin substrate on a glass microscope slide. The biotinylated target cells adhere to the avidin/streptavidin substrate, while the unbound cells are washed off and collected in a wicking member. Captured cells on the avidin/streptavidin substrate may then be visualized directly using a fluorescent microscope or detected and enumerated via an on-board fluorescent detection device. Additional chemicals and/or physical manipulation may then be applied to the device to release viable target cells for subsequent analysis.
    Type: Grant
    Filed: May 3, 2007
    Date of Patent: September 21, 2010
    Inventors: Amelia A. Ross, Steve Bernstein
  • Patent number: 7754155
    Abstract: A cell isolating device and method is provided to concentrate or isolate cells with specific characteristics from a mixture of different cell types. One embodiment may comprise two subtypes of antibodies that are directly conjugated to biotin (Abb) and conjugated to a fluorescent molecule (Abf). The conjugated antibodies (Abb+Abf) bind to the target cells in a mixed cell suspension. The cell suspension is then passed over an immobilized avidin or streptavidin substrate on a glass microscope slide. The biotinylated target cells adhere to the avidin/streptavidin substrate, while the unbound cells are washed off and collected in a wicking member. Captured cells on the avidin/streptavidin substrate may then be visualized directly using a fluorescent microscope or detected and enumerated via an on-board fluorescent detection device.
    Type: Grant
    Filed: September 18, 2002
    Date of Patent: July 13, 2010
    Inventors: Amelia A. Ross, Steve Bernstein
  • Publication number: 20070202530
    Abstract: A cell isolating device and method is provided to concentrate or isolate cells with specific characteristics from a mixture of different cell types. One embodiment may comprise two subtypes of antibodies that are directly conjugated to biotin (Abb) and conjugated to a fluorescent molecule (Abf). The conjugated antibodies (Abb+Abf) bind to the target cells in a mixed cell suspension. The cell suspension is then passed over an immobilized avidin or streptavidin substrate on a glass microscope slide. The biotinylated target cells adhere to the avidin/streptavidin substrate, while the unbound cells are washed off and collected in a wicking member. Captured cells on the avidin/streptavidin substrate may then be visualized directly using a fluorescent microscope or detected and enumerated via an on-board fluorescent detection device. Additional chemicals and/or physical manipulation may then be applied to the device to release viable target cells for subsequent analysis.
    Type: Application
    Filed: May 3, 2007
    Publication date: August 30, 2007
    Inventors: Amelia Ross, Steve Bernstein
  • Patent number: 6918518
    Abstract: A locking sizer tab and garment hanger combination is provided in which locking fingers of the sizer tab cooperatively lock into respective cross-bars formed in the neck of the hanger to prevent removal of the sizer tab from the hanger.
    Type: Grant
    Filed: May 5, 2003
    Date of Patent: July 19, 2005
    Inventors: Leslie S. Blitz, Steve Bernstein
  • Publication number: 20040222251
    Abstract: A locking sizer tab and garment hanger combination is provided in which locking fingers of the sizer tab cooperatively lock into respective cross-bars formed in the neck of the hanger to prevent removal of the sizer tab from the hanger.
    Type: Application
    Filed: May 5, 2003
    Publication date: November 11, 2004
    Inventors: Leslie S. Blitz, Steve Bernstein
  • Publication number: 20030175818
    Abstract: A cell isolating device and method is provided to concentrate or isolate cells with specific characteristics from a mixture of different cell types. One embodiment may comprise two subtypes of antibodies that are directly conjugated to biotin (Abb) and conjugated to a fluorescent molecule (Abf). The conjugated antibodies (Abb+Abf) bind to the target cells in a mixed cell suspension. The cell suspension is then passed over an immobilized avidin or streptavidin substrate on a glass microscope slide. The biotinylated target cells adhere to the avidin/streptavidin substrate, while the unbound cells are washed off and collected in a wicking member. Captured cells on the avidin/streptavidin substrate may then be visualized directly using a fluorescent microscope or detected and enumerated via an on-board fluorescent detection device. Additional chemicals and/or physical manipulation may then be applied to the device to release viable target cells for subsequent analysis.
    Type: Application
    Filed: September 18, 2002
    Publication date: September 18, 2003
    Inventors: Amelia A. Ross, Steve Bernstein
  • Publication number: 20030175850
    Abstract: A cell isolating device and method is provided to concentrate or isolate cells with specific characteristics from a mixture of different cell types. One embodiment may comprise two subtypes of antibodies that are directly conjugated to biotin (Abb) and conjugated to a fluorescent molecule (Abf). The conjugated antibodies (Abb+Abf) bind to the target cells in a mixed cell suspension. The cell suspension is then passed over an immobilized avidin or streptavidin substrate on a glass microscope slide. The biotinylated target cells adhere to the avidin/streptavidin substrate, while the unbound cells are washed off and collected in a wicking member. Captured cells on the avidin/streptavidin substrate may then be visualized directly using a fluorescent microscope or detected and enumerated via an on-board fluorescent detection device.
    Type: Application
    Filed: September 18, 2002
    Publication date: September 18, 2003
    Inventors: Amelia A. Ross, Steve Bernstein